Table of Content




1. Executive Summary


2. Global Computational Biology Market : Market Dynamics
2.1: Introduction, Background, and Classifications
2.2: Supply Chain
2.3: Industry Drivers and Challenges 


3. Market Trends and Forecast Analysis from 2018 to 2030
3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
3.2. Global Computational Biology Market Trends (2018-2023) and Forecast (2024-2030)

3.3: Global Computational Biology Market by Service
3.3.1: Contract
3.3.2: In-house

3.4: Global Computational Biology Market by Application
3.4.1: Cellular & Biological Simulation
3.4.2: Drug Discovery & Disease Modelling
3.4.3: Preclinical Drug Development
3.4.4: Clinical Trials
3.4.5: Human Body Simulation Software
3.4.6: Others

3.5: Global Computational Biology Market by End Use Industry
3.5.1: Academics & Research
3.5.2: Commercial
3.5.3: Others




4. Market Trends and Forecast Analysis by Region from 2018 to 2030
4.1: Global Computational Biology Market by Region
4.2: North American Computational Biology Market
4.2.1: North American Computational Biology Market by Application: Cellular & Biological Simulation, Drug Discovery & Disease Modelling, Preclinical Drug Development, Clinical Trials, Human Body Simulation Software, and Others
4.2.2: North American Computational Biology Market by End Use Industry: Academics & Research, Commercial, and Others

4.3: European Computational Biology Market

4.3.1: European Computational Biology Market by Application: Cellular & Biological Simulation, Drug Discovery & Disease Modelling, Preclinical Drug Development, Clinical Trials, Human Body Simulation Software, and Others
4.3.2: European Computational Biology Market by End Use Industry: Academics & Research, Commercial, and Others

4.4: APAC Computational Biology Market

4.4.1: APAC Computational Biology Market by Application: Cellular & Biological Simulation, Drug Discovery & Disease Modelling, Preclinical Drug Development, Clinical Trials, Human Body Simulation Software, and Others
4.4.2: APAC Computational Biology Market by End Use Industry: Academics & Research, Commercial, and Others

4.5: ROW Computational Biology Market

4.5.1: ROW Computational Biology Market by Application: Cellular & Biological Simulation, Drug Discovery & Disease Modelling, Preclinical Drug Development, Clinical Trials, Human Body Simulation Software, and Others
4.5.2: ROW Computational Biology Market by End Use Industry: Academics & Research, Commercial, and Others


5. Competitor Analysis
5.1: Product Portfolio Analysis
5.2: Operational Integration
5.3: Porter’s Five Forces Analysis


6. Growth Opportunities and Strategic Analysis
6.1: Growth Opportunity Analysis
6.1.1: Growth Opportunities for the Global Computational Biology Market by Service
6.1.2: Growth Opportunities for the Global Computational Biology Market by Application
6.1.3: Growth Opportunities for the Global Computational Biology Market by End Use Industry

6.1.4: Growth Opportunities for the Global Computational Biology Market by Region

6.2: Emerging Trends in the Global Computational Biology Market

6.3: Strategic Analysis
6.3.1: New Product Development
6.3.2: Capacity Expansion of the Global Computational Biology Market
6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Computational Biology Market
6.3.4: Certification and Licensing


7. Company Profiles of Leading Players
7.1: Genedata
7.2: Rhenovia Pharma
7.3: Compugen
7.4: Chemical Computing
7.5: Certara
7.6: Nimbus Discovery
7.7: Rhenovia Pharma & Leadscope
7.8: Simulation Plus
7.9: Entelos
7.10: Insilico Biotechnology